For example, an increased Cu requirement by prostate cancer cells because the presence of a mutant Cu-transporting Atp7b protein may change Cu-integration in serum and cause a remarkable reduction in prostate cancer burden and disease severity, abrogating adenocarcinoma development (48). This evidence concerns the gene ATP7B and prostate carcinoma.